Advertisement

Search Results

Advertisement



Article Topics

Your search for all items matches 221 pages

Showing 251 - 250

Advertisement

Advertisement



Jun
06
Today In Oncology
Early Local Therapy Did Not Extend Survival in Patients With Newly Diagnosed Metastatic Breast Cancer
Ivosidenib Plus Venetoclax With or Without Azacitidine for IDH1-Mutated AML
Durvalumab Added to Standard Chemotherapy Improved OS in Patients With Malignant Pleural Mesothelioma
Final Overall Survival Analysis of the PROSPER Trial in Nonmetastatic Castration-Resistant Prostate Cancer
First-Line Atezolizumab Plus Chemotherapy vs Chemotherapy Alone in Advanced Urothelial Cancer
View More 
Advertisement
Most Read Stories
TROPHIMMUN Trial Finds Avelumab Effective in Rare Gynecologic Tumor Resistant to Chemotherapy
Adjuvant Osimertinib ‘Exceeds Expectations’ in Early-Stage EGFR-Positive NSCLC
IMvigor130: First-Line Atezolizumab Plus Chemotherapy vs Chemotherapy Alone in Advanced Urothelial Cancer
Data From TAPUR Study Cohorts on Olaparib for BRCA-Mutated Advanced Prostate and Pancreatic Cancers
Final Overall Survival Analysis of the PROSPER Trial in Nonmetastatic Castration-Resistant Prostate Cancer
View More 
© 2020 HSP News Service, L.L.C.